vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and LiveRamp Holdings, Inc. (RAMP). Click either name above to swap in a different company.
LiveRamp Holdings, Inc. is the larger business by last-quarter revenue ($212.2M vs $123.8M, roughly 1.7× NATURES SUNSHINE PRODUCTS INC). LiveRamp Holdings, Inc. runs the higher net margin — 18.8% vs 3.3%, a 15.5% gap on every dollar of revenue. On growth, LiveRamp Holdings, Inc. posted the faster year-over-year revenue change (8.6% vs 4.7%). Over the past eight quarters, LiveRamp Holdings, Inc.'s revenue compounded faster (11.1% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
LiveRamp Holdings, Inc., is an American SaaS company that offers a data connectivity platform whose services include data onboarding, the transfer of offline data online for marketing purposes.
NATR vs RAMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $212.2M |
| Net Profit | $4.1M | $39.9M |
| Gross Margin | 72.5% | 71.9% |
| Operating Margin | 4.3% | 18.6% |
| Net Margin | 3.3% | 18.8% |
| Revenue YoY | 4.7% | 8.6% |
| Net Profit YoY | 1379.4% | 255.7% |
| EPS (diluted) | $0.23 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $212.2M | ||
| Q3 25 | $128.3M | $199.8M | ||
| Q2 25 | $114.8M | $194.8M | ||
| Q1 25 | $113.2M | $188.7M | ||
| Q4 24 | $118.2M | $195.4M | ||
| Q3 24 | $114.6M | $185.5M | ||
| Q2 24 | $110.6M | $176.0M | ||
| Q1 24 | $111.0M | $171.9M |
| Q4 25 | $4.1M | $39.9M | ||
| Q3 25 | $5.3M | $27.4M | ||
| Q2 25 | $5.3M | $7.7M | ||
| Q1 25 | $4.7M | $-6.3M | ||
| Q4 24 | $-321.0K | $11.2M | ||
| Q3 24 | $4.3M | $1.7M | ||
| Q2 24 | $1.3M | $-7.5M | ||
| Q1 24 | $2.3M | $-5.4M |
| Q4 25 | 72.5% | 71.9% | ||
| Q3 25 | 73.3% | 70.2% | ||
| Q2 25 | 71.7% | 70.1% | ||
| Q1 25 | 72.1% | 69.3% | ||
| Q4 24 | 72.0% | 71.9% | ||
| Q3 24 | 71.3% | 72.4% | ||
| Q2 24 | 71.4% | 70.6% | ||
| Q1 24 | 71.2% | 72.2% |
| Q4 25 | 4.3% | 18.6% | ||
| Q3 25 | 7.0% | 10.7% | ||
| Q2 25 | 3.7% | 3.7% | ||
| Q1 25 | 5.4% | -6.1% | ||
| Q4 24 | 3.8% | 7.5% | ||
| Q3 24 | 4.6% | 4.0% | ||
| Q2 24 | 5.1% | -3.0% | ||
| Q1 24 | 4.2% | -8.3% |
| Q4 25 | 3.3% | 18.8% | ||
| Q3 25 | 4.2% | 13.7% | ||
| Q2 25 | 4.6% | 4.0% | ||
| Q1 25 | 4.2% | -3.3% | ||
| Q4 24 | -0.3% | 5.7% | ||
| Q3 24 | 3.8% | 0.9% | ||
| Q2 24 | 1.2% | -4.3% | ||
| Q1 24 | 2.1% | -3.1% |
| Q4 25 | $0.23 | $0.62 | ||
| Q3 25 | $0.30 | $0.42 | ||
| Q2 25 | $0.28 | $0.12 | ||
| Q1 25 | $0.25 | $-0.10 | ||
| Q4 24 | $-0.02 | $0.17 | ||
| Q3 24 | $0.23 | $0.03 | ||
| Q2 24 | $0.07 | $-0.11 | ||
| Q1 24 | $0.12 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $403.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $962.3M |
| Total Assets | $261.1M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $403.4M | ||
| Q3 25 | $95.6M | $376.9M | ||
| Q2 25 | $81.3M | $371.1M | ||
| Q1 25 | $86.5M | $420.8M | ||
| Q4 24 | $84.7M | $384.3M | ||
| Q3 24 | $78.7M | $348.4M | ||
| Q2 24 | $68.7M | $342.7M | ||
| Q1 24 | $77.8M | $368.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $962.3M | ||
| Q3 25 | $166.7M | $943.8M | ||
| Q2 25 | $163.7M | $947.8M | ||
| Q1 25 | $167.1M | $948.9M | ||
| Q4 24 | $161.0M | $957.7M | ||
| Q3 24 | $162.6M | $932.1M | ||
| Q2 24 | $156.4M | $951.9M | ||
| Q1 24 | $159.7M | $949.1M |
| Q4 25 | $261.1M | $1.3B | ||
| Q3 25 | $264.8M | $1.2B | ||
| Q2 25 | $254.9M | $1.2B | ||
| Q1 25 | $252.7M | $1.3B | ||
| Q4 24 | $240.9M | $1.3B | ||
| Q3 24 | $245.3M | $1.2B | ||
| Q2 24 | $235.8M | $1.2B | ||
| Q1 24 | $247.3M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | — |
| Free Cash FlowOCF − Capex | $7.6M | — |
| FCF MarginFCF / Revenue | 6.1% | — |
| Capex IntensityCapex / Revenue | 1.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | — | ||
| Q3 25 | $18.5M | $57.4M | ||
| Q2 25 | $4.3M | $-15.8M | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $12.2M | $45.1M | ||
| Q3 24 | $9.6M | $55.6M | ||
| Q2 24 | $1.3M | $-9.3M | ||
| Q1 24 | $2.2M | — |
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | $56.8M | ||
| Q2 25 | $3.0M | $-16.2M | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $10.0M | $44.8M | ||
| Q3 24 | $7.9M | $55.4M | ||
| Q2 24 | $-2.0M | $-9.6M | ||
| Q1 24 | $-1.5M | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | 28.4% | ||
| Q2 25 | 2.6% | -8.3% | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 8.5% | 22.9% | ||
| Q3 24 | 6.9% | 29.8% | ||
| Q2 24 | -1.9% | -5.4% | ||
| Q1 24 | -1.4% | — |
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.3% | 0.3% | ||
| Q2 25 | 1.2% | 0.2% | ||
| Q1 25 | 1.0% | 0.2% | ||
| Q4 24 | 1.9% | 0.1% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 1.0% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 2.09× | ||
| Q2 25 | 0.81× | -2.04× | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | 2.21× | 32.10× | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RAMP
Segment breakdown not available.
